DAMBRACKAS WILLIAM A 4
4 · AVOCENT CORP · Filed Nov 14, 2003
Insider Transaction Report
Form 4
AVOCENT CORPAVCT
DAMBRACKAS WILLIAM A
Exec VP, Advanced Technology
Transactions
- Exercise/Conversion
Options (rights to buy)
2003-11-14−15,500→ 4,500 totalExercise: $22.36From: 2001-05-25Exp: 2011-05-25→ Common stock (15,500 underlying) - Exercise/Conversion
Options (rights to buy)
2003-11-12−11,000→ 9,000 totalExercise: $21.77From: 2002-04-15Exp: 2012-04-15→ Common Stock (11,000 underlying) - Exercise/Conversion
Common Stock
2003-11-12$21.77/sh+11,000$239,470→ 11,341 total - Sale
Common Stock
2003-11-12$37.30/sh−11,000$410,300→ 341 total - Exercise/Conversion
Common Stock
2003-11-13$29.31/sh+88,500$2,594,156→ 88,841 total - Sale
Common Stock
2003-11-13$37.82/sh−88,000$3,328,406→ 841 total - Exercise/Conversion
Common Stock
2003-11-14$22.36/sh+15,500$346,580→ 16,341 total - Sale
Common Stock
2003-11-14$38.25/sh−16,000$612,000→ 341 total - Exercise/Conversion
Options (rights to buy)
2003-11-13−88,500→ 31,500 totalExercise: $29.31From: 2001-01-03Exp: 2011-01-03→ Common Stock (88,500 underlying)
Holdings
- 30,000
Options (rights to buy)
Exercise: $27.25From: 2003-03-07Exp: 2013-03-07→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Grant date, 15% vests every six months for the first 12 months, 6.25% vests quarterly for the following 24 months and 5% vests quarterly for the remaining 12 months.
- [F2]Grant date, 25% vests after 6 months and in 10 equal quarterly installments thereafter.